Insider trade

Werewolf Therapeutics (HOWL): 10% owner sold ~$208K

GADICKE ANSBERT, 10% owner at Werewolf Therapeutics, sold ~$208K of Werewolf Therapeutics shares.

~$208K
Approx. value · 134K sh @ $1.55
6.44M
Holds after · shares reported
Traded
Oct 29, 2025
Filed
Oct 29, 2025

What stands out in this filing

  • The sale was 2.0% of the shares this insider held before it; the filing reports 6,442,653 shares, held indirectly afterwards.
  • 134,240 shares at an average of $1.55 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 2, 2025Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“Werewolf Therapeutics, Inc. (the “Company”) is saddened to report that Dr. Alon Lazarus, Ph.D., a member of the Company’s Board of Directors (the “Board”), passed away on September 30, 2025.”
  2. Oct 27, 2025Insider · 3 peopleInsiders: 3 sales (~$330K)
  3. Oct 28, 2025Insider · 3 peopleInsiders: 3 sales (~$299K)
  4. Oct 29, 2025 · this disclosureInsider10% owner sold ~$208K of HOWL shares in the open market

What came next

  1. Oct 29, 2025Insider · 2 peopleInsiders: 2 sales (~$342K)
  2. Oct 30, 2025Insider · 3 peopleInsiders: 3 sales (~$328K)
  3. Oct 31, 2025Insider · 3 peopleInsiders: 3 sales (~$386K)
  4. Nov 3, 2025Insider · 3 peopleInsiders: 3 sales (~$321K)
  5. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
  6. Nov 4, 2025Insider · 3 peopleInsiders: 3 sales (~$453K)
  7. Nov 5, 2025Insider · 3 peopleInsiders: 3 sales (~$155K)
  8. Nov 6, 2025Insider · 3 peopleInsiders: 3 sales (~$174K)
  9. Nov 7, 2025Insider · 3 peopleInsiders: 3 sales (~$201K)
  10. Nov 10, 2025Insider · 3 peopleInsiders: 3 sales (~$151K)
  11. Nov 11, 2025Insider · 3 peopleInsiders: 3 sales (~$168K)
  12. Nov 12, 2025Insider · 3 peopleInsiders: 3 sales (~$117K)
  13. Nov 13, 2025Insider · 3 peopleInsiders: 3 sales (~$235K)
  14. Nov 14, 2025Insider · 3 peopleInsiders: 3 sales (~$151K)
  15. Nov 17, 2025Insider · 3 peopleInsiders: 3 sales (~$143K)
  16. Nov 18, 2025Insider · 3 peopleInsiders: 3 sales (~$129K)
  17. Nov 19, 2025Insider · 3 peopleInsiders: 3 sales (~$165K)
  18. Nov 20, 2025Insider · 3 peopleInsiders: 3 sales (~$97K)
  19. Nov 21, 2025Insider · 3 peopleInsiders: 3 sales (~$141K)
  20. Nov 24, 2025Insider · 3 peopleInsiders: 3 sales (~$230K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Werewolf Therapeutics

For Werewolf Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HOWL page.

Other recent filings by GADICKE ANSBERT, 10% owner

The full history of GADICKE ANSBERT, 10% owner is on the profile page.

How this filing works

Explore the data

Common questions

Which Werewolf Therapeutics (HOWL) insider traded, and how much?

GADICKE ANSBERT, 10% owner at Werewolf Therapeutics, sold ~$208K of Werewolf Therapeutics shares. 134K shares at $1.55.

When did it happen, and when was it made public?

Traded: Oct 29, 2025. Filed: Oct 29, 2025.

What stands out in this filing?

The sale was 2.0% of the shares this insider held before it; the filing reports 6,442,653 shares, held indirectly afterwards. 134,240 shares at an average of $1.55 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Werewolf Therapeutics recently?

For Werewolf Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the HOWL page.

Does this mean HOWL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Werewolf Therapeutics

Everything OQRO holds on this company is on its HOWL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data